Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Duffield

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Frontiers in Oncology|November 16, 2020
A Phase 1 Study of IRX195183, a RARα-Selective CYP26 Resistant Retinoid, in Patients With Relapsed or Refractory AMLAlexander J Ambinder, Kelly Norsworthy, Daniela Hernandez, et al.
ASM Case Reports|November 17, 2025
Expedited diagnosis of disseminated <i>Mycobacterium kansasii</i> infection using targeted (amplicon-based) next-generation sequencing in an immunocompromised patientRisa Fuller, Bruce E Petersen, Shafinaz Hussein, et al.
American Journal of Clinical Pathology|May 15, 2023
Transformations of marginal zone lymphomas and lymphoplasmacytic lymphomas: Report from the 2021 SH/EAHP WorkshopJames R Cook, Catalina Amador, Magdalena Czader, et al.
American Journal of Clinical Pathology|April 21, 2023
Phenotypic and genotypic infidelity in B-lineage neoplasms, including transdifferentiation following targeted therapy: Report from the 2021 SH/EAHP WorkshopJohn R Goodlad, Wenbin Xiao, Catalina Amador, et al.
American Journal of Clinical Pathology|April 21, 2023
Progression of Hodgkin lymphoma and plasma cell neoplasms: Report from the 2021 SH/EAHP WorkshopReza Nejati, Catalina Amador, Magdalena Czader, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Frontiers in Oncology|November 16, 2020
A Phase 1 Study of IRX195183, a RARα-Selective CYP26 Resistant Retinoid, in Patients With Relapsed or Refractory AMLAlexander J Ambinder, Kelly Norsworthy, Daniela Hernandez, et al.
ASM Case Reports|November 17, 2025
Expedited diagnosis of disseminated <i>Mycobacterium kansasii</i> infection using targeted (amplicon-based) next-generation sequencing in an immunocompromised patientRisa Fuller, Bruce E Petersen, Shafinaz Hussein, et al.
American Journal of Clinical Pathology|May 15, 2023
Transformations of marginal zone lymphomas and lymphoplasmacytic lymphomas: Report from the 2021 SH/EAHP WorkshopJames R Cook, Catalina Amador, Magdalena Czader, et al.
American Journal of Clinical Pathology|April 21, 2023
Phenotypic and genotypic infidelity in B-lineage neoplasms, including transdifferentiation following targeted therapy: Report from the 2021 SH/EAHP WorkshopJohn R Goodlad, Wenbin Xiao, Catalina Amador, et al.
American Journal of Clinical Pathology|April 21, 2023
Progression of Hodgkin lymphoma and plasma cell neoplasms: Report from the 2021 SH/EAHP WorkshopReza Nejati, Catalina Amador, Magdalena Czader, et al.
Pageof 3